The emergence of acquired high-level resistance among Enterococcus species has renewed interest in mechanisms of resistance to glycopeptide antibiotics in gram-positive bacteria. In Enterococcus faecalis and Enterococcus faecium, resistance is encoded by the van gene cluster and is due to the production of a peptidoglycan precursor terminating in D-alanyl-D-lactate, to which vancomycin does not bind. Most
Glycopeptide antibiotics such as vancomycin act by binding to the D-alanyl-D-alanine terminus of stem pentapeptides present in bacterial peptidoglycan (16, 21) . It had been widely assumed that this terminus was ubiquitous among eubacterial species producing peptidoglycan and that vancomycin resistance was therefore unlikely to emerge in the absence of a barrier to vancomycin binding such as the outer membrane of gram-negative bacteria. However, high-level transmissible resistance to glycopeptides has recently been recognized among several gram-positive species, particularly enterococci, in which the incidence of resistance has been rising among clinical isolates (2) .
Most Leuconostoc and Pediococcus and some Lactobacillus species have been described as being intrinsically resistant to glycopeptides (9, 15, 17, 20) , but the mechanism of resistance has not been systematically investigated, perhaps because these organisms were considered to be of little clinical significance. However, the widespread use of vancomycin has led to more frequent recognition of these species as opportunistic pathogens (9, 20) . This trend, as well as the emergence of acquired vancomycin resistance in Enterococcus species, has renewed interest in the mechanism of resistance to glycopeptides.
In Enterococcus faecalis and Enterococcus faecium, highlevel resistance is inducible and mediated by plasmids harboring the van cluster of genes (2, 3) . This cluster includes vanH, which encodes an enzyme catalyzing the reduction of 2-keto acids to D-2-hydroxy acids (6) , and vanA, which encodes a ligase capable of adding either amino acids or hydroxy acids to D-alanine (5, 6 depsipeptide (D-alanyl-D-hydroxy acid) which is added in place of D-alanyl-D-alanine to the UDP-muramyl-tripeptide precursor, resulting in a peptidoglycan precursor that is not bound by vancomycin (6) . This hypothesis was supported by the observation that the MIC for resistant enterococci was diminished when tested with high concentrations of D-amino acids that can be incorporated into pentapeptide and that are bound by vancomycin to a greater extent than D-2-hydroxy acids (23) . Subsequently, the cytoplasmic peptidoglycan precursor in resistant E. faecium and E. faecalis was identified as UDP- 
The precursor extracts were chromatographically separated on-line with a Beckman System Gold high-performance liquid chromatograph (HPLC) and a Sciex API triple-quadrupole mass spectrometer equipped with an Ionspray interface, which can resolve 1 Da at up to 2,000 Da. The normal pentapeptide precursor, UDP-N-acetyl-muramyl-L-Ala-D-Glu-L-Lys-D-Ala-D-Ala, isolated from Staphylococcus aureus 209P, was used as a control.
Purified peptidoglycan was prepared from mid-logarithmicphase cultures of L. mesenteroides VR1. Cells were harvested by centrifugation, boiled with sodium dodecyl sulfate (SDS) (4%), washed extensively with water, and disrupted by vortexing with glass beads for 10 1-min pulses. Unbroken cells were removed by centrifugation, and the cell wall fraction was harvested by centrifugation and treated successively with DNase (10 ,ug/ml), RNase (50 ,ug/ml), trypsin (100 ,ug/ml), boiling SDS (1%), LiCl (8 M), and EDTA (100 mM).
Lyophilized cell wall material was incubated in 6 N HCl for 16 h at 110°C. Acid was removed from an aliquot by evaporation, and the preparation was suspended in 10 mM triethyl- amine buffer and incubated overnight with D-amino acid oxidase (20 p.g/ml) at 37°C. Treated and untreated aliquots were then subjected to amino acid analysis.
For both L. casei ATCC 7469 and L. mesenteroides VR1 the MIC of vancomycin was 1,024 ,ug/ml. When testing was performed with DL-alanine (200 mM), the MIC was reduced to 64 ,ug/ml for both strains. The diminution in MIC upon the addition of high concentrations of alanine suggested that these strains were resistant to vancomycin via a mechanism similar to that of acquired resistance in enterococci.
HPLC separation of precursor extracts from L. Fig. 1 and 2 . Tandem mass spectrometry was utilized to obtain structural information for the doubly charged ion (MH22+) of each precursor. A comparison of the tandem mass spectrometry fragmentation patterns of the precursors from L. mesenteroides VR1 and L. casei ATCC 7469 with the fragmentation template of the normal pentapeptide obtained from S. aureus indicated an alteration of an amino acid near the C terminus of each precursor. A key fragmentation route common to each precursor involved cleavage of the Glu-Lys amide bond. Fragment ions were observed to be consistent with the Lys-Ala-Ala (m/z 289), Lys-Ala-lactate (mlz 290), and Lys-(Ala)-Ala-lactate (m/z 361) substructures of the standard pentapeptide precursor (S. aureus), modified tetrapeptide precursor (L. casei), and modified pentapeptide precursor (L. mesenteroides), respectively. Consecutive tandem mass spectrometry fragmentations resulting in the neutral loss of the Ala-lactate substructure from the Glu-Lys-Ala-lactate and Glu-Lys-(Ala)-Ala-lactate fragment ions provide additional evidence for the proposed structural modification.
Previous investigators have identified a cytoplasmic hexapeptide precursor in bacterial species with interpeptide bridges of the structure L-Ala, L-Ala-L-Ser, or L-Ser-L-Ala which is present in some Lactobacillus and Leuconostoc spp. (13, 18) . In these organisms, the first amino acid of the interpeptide bridge is added to the --amino group of L-Lys at the level of the UDP-linked cytoplasmic precursor rather than at the lipid intermediate (18) . We therefore performed an amino acid analysis of peptidoglycan of strain VR1 to determine whether the additional alanine noted was of the L configuration consistent with such a precursor.
Amino acid analysis of peptidoglycan from strain VR1 yielded a Glu/Lys/Ala ratio of 1:1:3. After treatment of hydrolyzed cell wall with D-amino acid oxidase, amino acid analysis revealed a Glu/Lys/Ala ratio of 1:1:2, suggesting that two of the alanine residues were of the L configuration. Taken together, these results suggest the structure UDP-
The ability of vancomycin to bind the three precursors was studied by affinity capillary electrophoresis. This technique is based on the migration shifting before and after the formation of an affinity complex (4). The normal pentapeptide precursor,
from strain 209P, bound tightly to vancomycin, as indicated by migration shifting (Fig. 3A) . No shifting was observed under the same conditions for the precursor from L. mesenteroides VR1 (Fig. 3B) ; this is consistent with the proposed modification at the stem peptide terminus. A similar lack of shift was observed for L. casei ATCC 7469 (data not shown).
Although the genetics and mechanism of intrinsic resistance to glycopeptides among Leuconostoc and many Lactobacillus species have not been extensively studied since the identification of the phenomenon in the 1980s, this trait has been exploited in the selection of these organisms for genetic research and industrial applications (17, 19 (22) . Previous investigations had shown that vancomycin-resistant Leuconostoc and Lactobacillus isolates do not inactivate vancomycin (15, 17, 20) , but little systematic investigation of the mechanism of resistance had been undertaken, perhaps because of the isolates' apparent lack of pathogenicity. However, these organisms have been recognized more frequently in recent years as opportunistic pathogens (9, 20) . Furthermore, the recent emergence of enterococci with acquired glycopeptide resistance has renewed interest in organisms with intrinsic resistance, particularly as potential sources of the genetic elements present in the van gene cluster.
The relationship between acquired and intrinsic vancomycin resistance remains unclear. Recently, the van gene cluster associated with high-level resistance in enterococci has been shown to reside on a transposon, Tn1546 (3). Multiple regions of Tn1546 showed no relatedness with chromosomal DNA of susceptible E. faecalis or E. faecium by Southern hybridization or PCR amplification, suggesting that the van genes had originated from other species (3). Organisms demonstrating intrinsic resistance appear to be likely candidates for the origin of these genes, and conjugal transfer of other antibiotic resistance determinants between E. faecalis and both Leuconostoc and Lactobacillus species has been demonstrated (11, 19) .
The present findings demonstrate that the same mechanism of resistance, utilization of a peptidoglycan precursor terminating in lactate rather than alanine, functions in acquired high-level resistance in Enterococcus strains and intrinsic resistance in Leuconostoc and Lactobacillus species, suggesting that the van genes may have originated from an intrinsically resistant bacterium. However, a 290-bp probe internal to the vanA gene did not hybridize with DNA prepared from a number of Leuconostoc, Lactobacillus, or Pediococcus strains, even under moderately stringent conditions (7) . Similarly, no cross-reactivity between membranes prepared from these organisms and antiserum to the VanA protein was identified (15) . Further investigation will be needed to determine the relationship between the genetic determinants of acquired and intrinsic resistance to glycopeptide antibiotics. 
